borderline significantp = 0.05
Autovaccine treatment was associated with a borderline significant reduction in the prevalence of patients with >3 UTIs at 12 months (mean difference: 4.82; 95% CI: −0.10 to 9.64; p = 0.05).
Autovaccine treatment was associated with a borderline significant reduction in the prevalence of patients with >3 UTIs at 12 months (mean difference: 4.82; 95% CI: −0.10 to 9.64; p = 0.05).